We build the molecular tools your project needs, from complex cloning and genome editing to novel vector design and rare protein expression systems.

We design and optimize assays from the ground up and adapt high-sensitivity and cell-based formats, with robust controls, quality checks and clear reporting.

Independent reproducibility studies and scalability assessments to confirm the strength and potential of your asset.

Rapid, focused experiments that provide the decisive answers essential for investment due diligence and strategic pivots.

Expert advice on project design, troubleshooting and feasibility to set your experiments up for success.

Comprehensive protocols, QC data and method reports suitable for investor presentations, partnerships or regulatory submissions.